Brief: Prostatype Genomics Says Net Sales For Q3 Amounted To Approx 530 Tsek, Compared To 109 Tsek For Same Period Last Year
21/12/2023 17:35
Dec 21 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* NET SALES FOR Q3 OF 2023 AMOUNTED TO APPROX. 530 TSEK,
COMPARED
TO 109 TSEK FOR SAME PERIOD LAST YEAR
Source text for Eikon: ID:nWkr81673X
Further company coverage: PROGEN.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue